Kyung-Min Lee

10PUBLICATIONS
45CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesMolecular targetsCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 04, 2026
Cancer Immunotherapy: Therapeutic Limitations and Next-Generation Precision Strategies.

|Jun 12, 2026
Characterization of Rosa damascena Callus-Derived Exosome-like Vesicles and Their Multifunctional Activities in Skin-Related Cellular Models.

|Mar 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.

Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang

|Jul 28, 2023
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.

Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang

|Feb 25, 2023
Special Issue: Resistance to Targeted Therapies in Human Cancer.

Tae-Won Lee, Hee-Joo Choi, Kyung-Min Lee

|Oct 24, 2022
Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells.

Seogho Son, Seung-Ah Yoo, KeeSoo Nam

Pageof 2

Frequent Collaborators

4 joint publications

Ariella B Hanker

4 joint publications

Carlos L Arteaga

2 joint publications

Paula I González Ericsson

2 joint publications

Lin Xu